Coloplast A/S (CLPBF)
68.32
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Coloplast Enterprise Value : 18.91B for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 18.91B |
| August 25, 2026 | 18.91B |
| August 24, 2026 | 18.91B |
| August 21, 2026 | 18.91B |
| August 20, 2026 | 18.91B |
| August 19, 2026 | 18.45B |
| August 18, 2026 | 18.45B |
| August 17, 2026 | 18.22B |
| August 14, 2026 | 18.17B |
| August 13, 2026 | 18.17B |
| August 12, 2026 | 18.17B |
| August 11, 2026 | 18.70B |
| August 10, 2026 | 18.23B |
| August 07, 2026 | 18.23B |
| August 06, 2026 | 18.23B |
| August 05, 2026 | 18.23B |
| August 04, 2026 | 18.34B |
| August 03, 2026 | 18.34B |
| July 31, 2026 | 18.34B |
| July 30, 2026 | 18.34B |
| July 29, 2026 | 18.10B |
| July 28, 2026 | 18.16B |
| July 27, 2026 | 17.94B |
| July 24, 2026 | 17.94B |
| July 23, 2026 | 17.94B |
| Date | Value |
|---|---|
| July 22, 2026 | 17.94B |
| July 21, 2026 | 17.94B |
| July 20, 2026 | 17.05B |
| July 17, 2026 | 17.05B |
| July 16, 2026 | 17.05B |
| July 15, 2026 | 17.05B |
| July 14, 2026 | 17.05B |
| July 13, 2026 | 17.43B |
| July 10, 2026 | 17.43B |
| July 09, 2026 | 17.43B |
| July 08, 2026 | 17.10B |
| July 07, 2026 | 17.51B |
| July 06, 2026 | 17.05B |
| July 02, 2026 | 17.14B |
| July 01, 2026 | 16.34B |
| June 30, 2026 | 16.34B |
| June 29, 2026 | 16.51B |
| June 26, 2026 | 16.51B |
| June 25, 2026 | 16.51B |
| June 24, 2026 | 16.51B |
| June 23, 2026 | 16.42B |
| June 22, 2026 | 16.42B |
| June 18, 2026 | 16.42B |
| June 17, 2026 | 16.37B |
| June 16, 2026 | 16.37B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ambu A/S | 3.019B |
| Abbott Laboratories | 225.09B |
| AngioDynamics, Inc. | 611.37M |
| Alphatec Holdings, Inc. | 1.947B |
| AtriCure, Inc. | 2.357B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 227.46M |
| Revenue (Quarterly) | 1.144B |
| Total Expenses (Quarterly) | 916.84M |
| EPS Diluted (Quarterly) | 1.009 |
| Gross Profit Margin (Quarterly) | 66.73% |
| Profit Margin (Quarterly) | 19.88% |
| Earnings Yield | 2.79% |
| Operating Earnings Yield | 7.57% |
| Normalized Earnings Yield | 5.043 |